Every year, October serves as a global reminder of the importance of awareness and early detection in the fight against breast cancer. For Pink October 2025, CRITT M2A proudly reaffirms its commitment to supporting all those affected by this disease. By participating in this international movement, we seek to highlight the crucial role of prevention, early diagnosis, and medical research.
Breast cancer remains the most common cancer among women worldwide, yet continuous progress in science and technology has greatly improved survival rates. As a leading center for innovation and applied research, CRITT M2A is deeply committed to promoting health, responsibility, and solidarity. Our participation in Pink October is a way to raise awareness among our partners, collaborators, and the wider community about the importance of screening and supporting scientific advancement.
Pink October is also a time to remember that prevention begins with knowledge. Each of us has the power to act—by learning about screening, spreading awareness, and supporting research initiatives that drive medical progress. CRITT M2A stands alongside all those who contribute to this vital cause and reaffirms its belief that collective action can change lives. Together, we can build a healthier future where innovation and research serve the well-being of everyone.
